Skip to content

Amarin loses appeals court ruling on Vascepa

September 3, 2020

Amarin’s (NASDAQ:AMRN) bid to revive patents on heart treatment Vascepa has failed, with a U.S. Court of Appeals – just one day after hearing arguments – has affirmed the previous trial court ruling.

Jefferies says the Rule 36 judgement makes the odds about zero that the ruling can be appealed for en banc review or to the Supreme Court.

https://seekingalpha.com/news/3611464-amarin-loses-appeals-court-ruling-on-vascepa

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: